Standard Patient Training Versus Vik Chatbot Guided Training: a Randomized Controlled Trial for A… (NCT05248126) | Clinical Trial Compass
CompletedNot Applicable
Standard Patient Training Versus Vik Chatbot Guided Training: a Randomized Controlled Trial for Asthma Patients
France73 participantsStarted 2022-05-24
Plain-language summary
The onset of smartphone usage has provided new opportunities for managing patients outside the walls of healthcare facilities. The development of asthma-specific smartphone applications represents an excellent area for partnership between developers and medical teams for delivering therapeutic education at the required time and in a personalised way. Within this context, the overall goal of the AsthmaTrain study is to perform a first, small pilot study comparing a new French-language chat-bot guided asthma patient education programme (the 'Vik' application) with the classic, authority-approved patient education program at the University Hospitals of Montpellier, Montpellier, France.
The primary objective is to compare a population of adult patients with asthma and participating in a standard patient education programme with a similar population participating in Vik-guided education programme in terms of change in overall scores on the Asthma Quality of Life Questionnaire (AQLQ).
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Minimum age: 18
* Physician-confirmed diagnosis of asthma
Exclusion Criteria:
* Protected populations according to the French Public Health Code Articles L1121-6,8
* The subject has already participated in the present study
* Subject unable to comply with trial procedures/visits
* Potential for interference from another study
* Non-beneficiary of the French single-payer national medical insurance system
* Lack of informed consent
* Patients already using the Vik Asthma application in their daily lives or having already followed a therapeutic education program
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial compared a chatbot called Vik against standard patient training for asthma — since the trial is now completed, has the data been published yet, and what did it show about whether the chatbot actually improved quality of life scores compared to the usual training approach?
2The trial measured changes in something called the AQLQ score — can you explain what that questionnaire measures and whether improvements in that score tend to translate into real-life differences that asthma patients actually notice day to day?
3Since this study was about patient education and training rather than a new drug or procedure, what does my current asthma education look like, and is there anything from this kind of chatbot-guided approach that you think could benefit how I manage my condition right now?
4This trial had no assigned phase, which suggests it was testing a digital health tool rather than a medication — does that mean the safety considerations are different, and are there any concerns about relying on an app-based tool for asthma self-management that I should be aware of?
5Are there other completed or ongoing studies on digital or app-based asthma management that you think are worth looking into alongside this one, or do you feel standard in-person training is still the better option for someone in my situation?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.